Published in Nephron on January 01, 1993
Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc Natl Acad Sci U S A (1994) 1.33
Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci U S A (1994) 1.33
Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc Natl Acad Sci U S A (1996) 1.11
Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J Clin Invest (1996) 0.99
Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br J Pharmacol (1994) 0.95
Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1 beta-stimulated rat mesangial cells. J Clin Invest (1995) 0.94
Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells. Biochem J (1999) 0.92
Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells. Biochem J (1996) 0.88
Dexamethasone differentially affects interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase mRNA expression in renal mesangial cells. Biochem J (1994) 0.86
Possible role of protein kinase C-epsilon isoenzyme in inhibition of interleukin 1 beta induction of nitric oxide synthase in rat renal mesangial cells. Biochem J (1994) 0.83
Apoptosis and expression of inducible nitric oxide synthase are mutually exclusive in renal mesangial cells. Am J Pathol (1997) 0.77
Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain (2000) 2.04
Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol (1998) 2.00
Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol (1999) 1.58
Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am J Psychiatry (2000) 1.53
Use of frequency-modulated radiofrequency pulses in MR imaging experiments. Magn Reson Med (1986) 1.42
Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc Natl Acad Sci U S A (1994) 1.33
Interrater reliability between scorers from eight European sleep laboratories in subjects with different sleep disorders. J Sleep Res (2004) 1.33
Spectroscopy and imaging with a 4 tesla whole-body MR system. NMR Biomed (1988) 1.28
Functional imaging of mitochondria in saponin-permeabilized mice muscle fibers. J Cell Biol (1998) 1.20
Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol (2001) 1.19
Cervical stability after foraminotomy. A biomechanical in vitro analysis. J Bone Joint Surg Am (1992) 1.18
The SIESTA project polygraphic and clinical database. IEEE Eng Med Biol Mag (2001) 1.16
Endoscopic treatment of clinically symptomatic leaks of thoracic esophageal anastomoses. Gastrointest Endosc (2000) 1.11
Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat. Ann N Y Acad Sci (1989) 1.10
Platelet concentrates derived from buffy coat and apheresis: biochemical and functional differences. Transfus Med (2002) 1.10
Self-reported empathic abilities in schizophrenia. Schizophr Res (2007) 1.08
Inducible NO synthase: role in cellular signalling. J Exp Biol (1999) 1.06
Molecular cloning of cDNA sequences for rat alpha 2-macroglobulin and measurement of its transcription during experimental inflammation. J Biol Chem (1985) 1.00
Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig Dis Sci (1998) 0.97
Pyrrolidine dithiocarbamate differentially affects interleukin 1 beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. Biochem Biophys Res Commun (1994) 0.97
Hippocampal glutamate concentration predicts cerebral theta oscillations during cognitive processing. Psychopharmacology (Berl) (2006) 0.96
Membrane-bound peptidases of lymphocytes: functional implications. Biomed Biochim Acta (1991) 0.95
Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial. Clin Pharmacol Ther (2012) 0.95
Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br J Pharmacol (1994) 0.95
Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation. J Interferon Cytokine Res (1999) 0.94
Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors. Molecular cloning of the mouse C5a anaphylatoxin receptor. J Immunol (1992) 0.93
Pituitary deficiency following aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2003) 0.93
Molecular cloning of the rat inducible nitric oxide synthase gene promoter. Biochem Biophys Res Commun (1996) 0.92
Association between cerebral glutamate and human behaviour: the sensation seeking personality trait. Neuroimage (2006) 0.92
Cyclosporin derivatives inhibit interleukin 1 beta induction of nitric oxide synthase in renal mesangial cells. Eur J Pharmacol (1993) 0.92
Cytokines and neurotrophins interact in normal and diseased states. Ann N Y Acad Sci (2000) 0.92
IL-18 is expressed in the intercalated cell of human kidney. Kidney Int (2007) 0.92
Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci (1999) 0.91
Hemangiopericytoma in pediatric ages: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. Cancer (2001) 0.90
Frequency-modulated radiofrequency pulses in spin-echo and stimulated-echo experiments. Magn Reson Med (1987) 0.89
Lack of interferon-gamma production despite the presence of interleukin-18 during cutaneous wound healing. Mol Med (2000) 0.88
Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo. Clin Exp Immunol (2009) 0.88
MR imaging using stimulated echoes (STEAM). Radiology (1986) 0.86
Lack of association between the -260 C-->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels. Intensive Care Med (2001) 0.86
Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem (2000) 0.86
Lack of in vivo function of CD31 in vascular thrombosis. Thromb Haemost (2001) 0.86
[Restless legs syndrome, periodic limb movements, and psychopharmacology]. Nervenarzt (2008) 0.86
Peritoneal release of TNFalpha and IL-6 after elective colorectal surgery and anastomotic leakage. J Invest Surg (2003) 0.86
Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells. Nat Immun (1995) 0.86
Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts. BMC Cell Biol (2000) 0.84
Interferon-gamma induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes. Rheumatology (Oxford) (2003) 0.84
Pyrrolidine dithiocarbamate differentially affects cytokine- and cAMP-induced expression of group II phospholipase A2 in rat renal mesangial cells. FEBS Lett (1995) 0.83
Quality control of polysomnographic sleep data by histogram and entropy analysis. Clin Neurophysiol (1999) 0.82
Interleukin 1 and tumor necrosis factor potentiate angiotensin II- and calcium ionophore-stimulated prostaglandin E2 synthesis in rat renal mesangial cells. Biochem Biophys Res Commun (1990) 0.81
Effects of interleukin-6 (IL-6) and transforming growth factor-beta (TGF-beta) on neutrophil elastase release. Inflammation (1995) 0.81
Therapeutic strategies for the inhibition of inducible nitric oxide synthase--potential for a novel class of anti-inflammatory agents. Cell Biol Int (1996) 0.81
Computed tomography of the human pineal gland for study of the sleep-wake rhythm: reproducibility of a semi-quantitative approach. Acta Radiol (2006) 0.80
Suppression by cyclosporin A of interleukin 1 beta-induced expression of group II phospholipase A2 in rat renal mesangial cells. Br J Pharmacol (1997) 0.80
QRS prolongation on surface ECG and brain natriuretic peptide as indicators of left ventricular systolic dysfunction. J Intern Med (2004) 0.79
Immunopharmacology: anti-inflammatory therapy targeting transcription factors. Eur J Pharmacol (1999) 0.79
Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced group II phospholipase A2 expression in rat renal mesangial cells. Biochim Biophys Acta (1998) 0.79
Cytokine regulation of group II phospholipase A2 expression in glomerular mesangial cells. Eur J Clin Pharmacol (1993) 0.79
The Double Sensor-A non-invasive device to continuously monitor core temperature in humans on earth and in space. Respir Physiol Neurobiol (2009) 0.79
[Bilateral laparoscopic transperitoneal adrenalectomy in pheochromocytoma]. Langenbecks Arch Chir (1997) 0.79
Results of exercise testing at a mean age of 10 years after neonatal arterial switch operation. Acta Paediatr (2003) 0.78
Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease. J Am Coll Cardiol (1999) 0.78
Regulation of interleukin-18 (IL-18) expression in keratinocytes (HaCaT): implications for early wound healing. Eur Cytokine Netw (2000) 0.78
Proteolytic cleavage of inducible nitric oxide synthase (iNOS) by calpain I. Biochim Biophys Acta (2001) 0.78
Apoptosis and expression of inducible nitric oxide synthase are mutually exclusive in renal mesangial cells. Am J Pathol (1997) 0.77
Regulation of alpha 2-macroglobulin gene expression by interleukin-6 (BSF-2/HSF). Tokai J Exp Clin Med (1988) 0.77
Expression of interleukin-6 and its receptor in the sciatic nerve and cultured Schwann cells: relation to 18-kD fibroblast growth factor-2. Brain Res (2000) 0.77
Spatial resolution of transcranial pulsed Doppler technique in vitro evaluation of the sensitivity distribution of the sample volume. Ultrasound Med Biol (1989) 0.77
Spontaneous and inducible cytokine responses in healthy humans receiving a single dose of IFN-alpha2b: increased production of interleukin-1 receptor antagonist and suppression of IL-1-induced IL-8. J Interferon Cytokine Res (1998) 0.77
Modulatory role of platelet-derived growth factor on cytokine-induced nerve growth factor synthesis in rat glomerular mesangial cells. Biochem J (1995) 0.77
The influence of the tricyclic antidepressant amitriptyline on periodic limb movements during sleep. Pharmacopsychiatry (2013) 0.76
Energy metabolism in rat pancreatic acinar cells during anoxia and reoxygenation. Biochim Biophys Acta (1998) 0.76
Patterns of pseudo-reticulocytosis in malaria: fluorescent analysis with the Cell-Dyn CD4000. Clin Lab Haematol (2002) 0.76
Signals regulating neurotrophin expression in glial cells. Prog Brain Res (2001) 0.76
Tetranactin inhibits interleukin 1 beta and cAMP induction of group II phospholipase A2 in rat renal mesangial cells. Eur J Pharmacol (1996) 0.76
Biosynthesis of rat alpha 2-macroglobulin. Biochem Soc Trans (1985) 0.75
Proteases of isolated pancreatic acinar cells after caerulein hyperstimulation. Adv Exp Med Biol (1997) 0.75
[Peritonitis models in the rat with special reference to laparoscopic therapy options]. Zentralbl Chir (1999) 0.75
Double pulse echoes--a novel approach for fat-water separation in magnetic resonance imaging. Magn Reson Med (1986) 0.75
[X-ray morphologic kidney changes in hypertension. Study of 426 patients with chronic hypertension]. Z Gesamte Inn Med (1970) 0.75
[Thiocarbonic acid-S-esters and their polarographic behavior]. Pharmazie (1969) 0.75
[Laparoscopic transperitoneal adrenalectomy--technique and personal experiences]. Zentralbl Chir (1997) 0.75
Cytokine regulation of nitric oxide synthase expression in glomerular mesangial cells. Exp Nephrol (1994) 0.75
Selective proteolytical cleavage of the ligand-binding chains of the IL-2-receptor and IL-6-receptor by neutrophil-derived proteases. Adv Exp Med Biol (1997) 0.75
Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing. Pharmacopsychiatry (2005) 0.75
[Cellular and humoral functions in acute pancreatitis]. Wien Med Wochenschr (1997) 0.75
[Regional resolution power of pulsed Doppler ultrasound as a function of signal amplitude]. Biomed Tech (Berl) (1990) 0.75
On the analysis of the cat's pattern recognition system. Biol Cybern (1983) 0.75
[Results with cyclophosphamide therapy in single and massive dosage]. Z Gesamte Inn Med (1967) 0.75
[Presentation of the self concept of drug-dependent patients in their personal records]. Prax Kinderpsychol Kinderpsychiatr (1985) 0.75
Real-time PCR assay with fluorescent hybridization probes for rapid genotyping of the CD14 promotor polymorphism. Clin Chem (2000) 0.75
EXAFS study of U(VI) uptake by calcium silicate hydrates. J Colloid Interface Sci (2006) 0.75
Regulation of proteinase activity by high molecular weight inhibitors: biosynthesis of rat alpha-macroglobulins. Adv Exp Med Biol (1988) 0.75
[Integration and maladjustment of drug addicts following treatment in a therapeutic community]. Prax Kinderpsychol Kinderpsychiatr (1984) 0.75
[Interleukin pattern, procalcitonin level and cellular immune status after endovascular aneurysm surgery]. Zentralbl Chir (2000) 0.75